University of British Columbia
Identification and evaluation of potential candidate antigens for vaccine development against Klebsiella pneumoniae
Abstract
dc:descriptionKlebsiella pneumoniae is a growing threat to public health due to increased antibiotic resistance. K. pneumoniae is a leading cause of infections in healthy and immunocompromised children and adults, causing pneumonia, bacteremia, intra-abdominal abscesses, and urinary tract infections. Immunization is the ideal long-term approach to prevent K. pneumoniae infections. In 1988, a 24-valent polysaccharide vaccine targeting the most predominant capsular (divided into different K-types) types of K. pneumoniae was tested in several Phase 1 clinical trials. However, this is the first vaccine that has moved from pre-clinical testing to human clinical trials. In this work, a representative collection of global bloodstream K. pneumoniae isolates was used to assess the predicted vaccine coverage of the capsule and lipopolysaccharide (LPS) O-antigen in K. pneumoniae, the two main virulence factors of this pathogen. The genomics investigation revealed that at least 20 capsular polysaccharide types would need to be included in a polysaccharide vaccine to achieve broad vaccine coverage (approximately 70-80%) while targeting the two most predominant LPS O-antigens (O1 and O2 types) is predicted to achieve a coverage of 76.5%. Moreover, a ‘pan-genomic’ investigation was performed to identify additional vaccine targets with predicted broad coverage. This approach revealed 85 surface-exposed proteins in at least 80% of the strains. Of these 85 identified surface-exposed proteins, some have been previously proposed as candidate targets for a K. pneumoniae vaccine. To expand the knowledge of K. pneumoniae antigenic targets, 10 surface-exposed proteins were selected for further evaluation as candidate vaccine targets. These antigenic targets were expressed separately in an outer membrane vesicle vaccine platform formulated with aluminum adjuvant and assessed for their immunogenicity and protective efficacy in a murine immunization-challenge model. Three of the five candidate vaccines elicited an IgG response to the target antigens and K. pneumoniae. However, upon intranasal challenge, all animals immunized with the candidate vaccines showed disease worsening, high mortality, and bacterial dissemination compared to naïve animals. Although candidate vaccines evaluated in this work were not shown to be protective, the pan-genomic investigation approach revealed surface-exposed proteins with predicted broad coverage for potential evaluation as candidate targets for a K. pneumoniae protein-based vaccine.
Degree
thesis:*- Name thesis:degree_name
- Master of Science - MSc
- Level thesis:degree_level
- master's
- Discipline thesis:degree_discipline
- Experimental Medicine
- Grantor dc:publisher
- University of British Columbia
- Year dc:date
- 2023
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- Cabrera, Adriana
- Contributors dc:contributor
-
- Sadarangani, Manish
Rights
dc:rights- Statement dc:rights
-
- Attribution-NonCommercial-NoDerivatives 4.0 International
- Language dc:language
- eng
Identifiers
dc:identifier.*- Handle dc:identifier
- http://hdl.handle.net/2429/83829